Navigation Links
Pradaxa Lawsuit Update: Bernstein Liebhard LLP Notes Filings in Federal Pradaxa Litigation Surpass 700

New York, NY (PRWEB) May 15, 2013

Pradaxa lawsuit filings continue to mount in the federal multidistrict litigation now underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to the Court’s website, 705 claims have been filed in the litigation on behalf of individuals who allegedly suffered life-threatening internal bleeding while using Pradaxa.( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are not at all surprised that the filings in this litigation are increasing at such a rapid pace. Our Firm continues to hear from alleged victims of Pradaxa side effects on a regular basis,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Side Effects
Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent strokes in people with atrial fibrillation. The drug was touted as an improvement over decades-old warfarin, but reported in December that regulators in several countries have issued alerts regarding the drug’s potential to cause dangerous internal bleeding in some patients. Most problematic is the fact that there exists no readily-available antidote for internal bleeding, a potentially life-threatening Pradaxa side effect. *

In January, an analysis of FDA hemorrhage cases published in the Institute for Safe Medication Practice’s QuarterWatch report revealed Pradaxa bleeding to be 5 times more likely to result in death compared to warfarin bleeding.** Most recently, a study published May 1st in the Journal of Neurosurgery found that head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa compared to those taking warfarin. The study authors surmised that the lack of an effective reversal agent could account for the higher death rate among Pradaxa patients.***

Court documents indicate that the first trial in the federal Pradaxa litigation is scheduled to begin in September 2014. Plaintiffs with claims pending in the litigation allege that Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for Pradaxa bleeding.

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa lawsuits is available at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
2. Rottenstein Law Group LLP Responds to Study Linking Pradaxa Side Effects with Potential Mortality Risks
3. Update on Pradaxa Internal Bleeding Problem Allegations Lawsuits; Resource4thePeople Reports Bellwether Trial Dates Scheduled
4. Pradaxa Lawyers at Bernstein Liebhard LLP Comment on New Study Highlighting the Risk of Pradaxa Brain Bleeding
5. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
6. Pradaxa Lawsuits Move Forward, With Scheduling of Next Status Conference in Federal Pradaxa Litigation, Bernstein Liebhard LLP Reports
7. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
8. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
9. DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
10. 2013 Cases Involving Pradaxa Internal Bleeding Problem Allegations Now Being Investigated by Resource4thePeople Lawyers
11. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday ... dish and pleasing the palates of attendees is of the utmost importance. Whether ... a seasonal get-together, give these recipes a try this holiday season. , Turkey ...
(Date:11/25/2015)... Nairobi (PRWEB) , ... November 26, 2015 , ... ... African Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, ... Nations Office in Nairobi (UNON) for the opening of the 5th African Network ...
(Date:11/25/2015)... ... 25, 2015 , ... Dental professionals who would like to become more proficient ... attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held ... the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud ...
(Date:11/25/2015)... ... 2015 , ... Smiles by Stevens is pleased to announce the ... While many patients are aware of the benefits of Botox® in the treatment of ... suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a ... “I thought there had to be a convenient and comfortable way to protect them ... enables disabled individuals to safely travel during cold or inclement weather. In doing so, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- ) has announced the ... Viscosity Drugs" report to their offering. ... of the "Self Administration of High Viscosity ... Research and Markets ( ) has ... of High Viscosity Drugs" report to their ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: